Draghia-Akli Ruxandra has filed 13 insider transactions across 1 company since November 2024.
Most recent transaction: a grant/award of 139500 shares of NOVAVAX INC ($NVAX) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | EVP, Research & Development | A | Non-Statutory Stock Option NQ | 139500 | $0.00 | 139,500.0000 | 168,195,000 | 9999.99% | 0.08% |
| March 3, 2026 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | EVP, Research & Development | F | Common Stock | 11313 | $9.49 | 23,563.0000 | 168,195,000 | 32.44% | 0.01% |
| March 3, 2026 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | EVP, Research & Development | M | Common Stock | 26667 | $0.00 | 34,876.0000 | 168,195,000 | 324.85% | 0.02% |
| March 2, 2026 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | EVP, Research & Development | A | Restricted Stock Units | 93000 | $0.00 | 101,000.0000 | 168,195,000 | 1162.50% | 0.06% |
| March 3, 2026 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | EVP, Research & Development | D | Restricted Stock Units | 26667 | $0.00 | 53,333.0000 | 168,195,000 | 33.33% | 0.02% |
| March 2, 2026 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | EVP, Research & Development | A | Non-Statutory Stock Opotion NQ | 139500 | $9.09 | 139,500.0000 | 168,195,000 | 9999.99% | 0.08% |
| Nov. 11, 2025 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | Section 16 | D | Restricted Stock Units | 14257 | $0.00 | 28,513.0000 | 168,195,000 | 33.33% | 0.01% |
| Nov. 11, 2025 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | Section 16 | M | Common Stock | 14257 | $0.00 | 14,257.0000 | 168,195,000 | 9999.99% | 0.01% |
| Nov. 11, 2025 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | Section 16 | F | Common Stock | 6048 | $7.40 | 8,209.0000 | 168,195,000 | 42.42% | 0.00% |
| March 3, 2025 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | Section 16 | A | 2025 Non-statutory Stock Option NQ | 120000 | $7.87 | 120,000.0000 | 152,190,000 | 9999.99% | 0.08% |
| March 3, 2025 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | Section 16 | A | 2025 Restricted Stock Units RSU | 80000 | $0.00 | 80,000.0000 | 152,190,000 | 9999.99% | 0.05% |
| Nov. 11, 2024 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | Section 16 | A | Restricted Stock Units | 42770 | $0.00 | 42,770.0000 | 160,049,000 | 9999.99% | 0.03% |
| Nov. 11, 2024 | NOVAVAX INC | $NVAX | Draghia-Akli Ruxandra | Section 16 | A | Stock Option (Right to Buy) | 64150 | $9.01 | 64,150.0000 | 160,049,000 | 9999.99% | 0.04% |